Patents by Inventor Robert E. Morrow

Robert E. Morrow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190375285
    Abstract: An energy storage system comprising at least one energy storage module adapted to supply electrical energy to a hybrid vehicle. The energy storage module comprises an enclosure, at least one battery array located within the enclosure, and an energy storage controller module located within the enclosure and electrically connected to the battery array. The energy storage module further comprises a compliant tipped thermistor which may be installed within a flexible clip. The thermistor is positioned to monitor the temperature of one or more of the batteries within the energy storage system.
    Type: Application
    Filed: August 23, 2019
    Publication date: December 12, 2019
    Applicant: Allison Transmission, Inc.
    Inventors: Brian J. Maskew, Scott K. Bennett, Leonard F. Baxter, II, Daniel J. Youngs, Kurt Biehl, Edward Bass, Eric D. Schneider, Felice E. Bailey, Steven T. Reyburn, Dean M. Ford, Clyde E. Johnson, Bruce E. Miller, Richard Bletsis, Derek A. Delrymple, Markus Naegeli, Jerry Wendling, Timothy A. Gasaway, Russell B. Hopkins, Brian C. Morrow, Robert Lawrence
  • Patent number: 10421349
    Abstract: An energy storage system comprising at least one energy storage module adapted to supply electrical energy to a hybrid vehicle. The energy storage module comprises an enclosure, at least one battery array located within the enclosure, and an energy storage controller module located within the enclosure and electrically connected to the battery array. The energy storage module further comprises a compliant tipped thermistor which may be installed within a flexible clip. The thermistor is positioned to monitor the temperature of one or more of the batteries within the energy storage system.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: September 24, 2019
    Assignee: Allison Transmission, Inc.
    Inventors: Brian J. Maskew, Scott K. Bennett, Leonard F. Baxter, II, Daniel J. Youngs, Kurt Biehl, Edward Bass, Eric D. Schneider, Felice E. Bailey, Steven T. Reyburn, Dean M. Ford, Clyde E. Johnson, Bruce E. Miller, Richard Bletsis, Derek A. Delrymple, Markus Naegeli, Jerry Wendling, Timothy A. Gasaway, Russell B. Hopkins, Brian C. Morrow, Robert Lawrence
  • Patent number: 10322627
    Abstract: An energy storage system comprising at least one energy storage module adapted to supply electrical energy to a hybrid vehicle. The energy storage module comprises an enclosure, at least one battery array located within the enclosure, and an energy storage controller module located within the enclosure and electrically connected to the battery array. The energy storage module further comprises a compliant tipped thermistor which may be installed within a flexible clip. The thermistor is positioned to monitor the temperature of one or more of the batteries within the energy storage system.
    Type: Grant
    Filed: April 11, 2016
    Date of Patent: June 18, 2019
    Assignee: Allison Transmission, Inc.
    Inventors: Brian J. Maskew, Scott K. Bennett, Leonard F. Baxter, II, Daniel J. Youngs, Kurt Biehl, Edward Bass, Eric D. Schneider, Felice E. Bailey, Steven T. Reyburn, Dean M. Ford, Clyde E. Johnson, Bruce E. Miller, Richard Bletsis, Derek A. Delrymple, Markus Naegell, Jerry Wendling, Timothy A. Gasaway, Russell B. Hopkins, Brian C. Morrow, Robert A. Lawrence
  • Patent number: 5731008
    Abstract: A microbiocidal solution for in vivo and in vitro treatment of microbial infections contains an electrolyzed saline containing regulated amounts of ozone and active chlorine species wherein the ozone content is between about 5 and 100 mg/L and the active chlorine species content of between about 5 and 300 ppm. The active chlorine species contains free chlorine, hypochlorous acid and the hypochlorite ion as measured by a chlorine selective electrode. The solution is prepared by subjecting a 1% or less saline to electrolysis under conditions sufficient to produce the desired active ingredients. The solution is preferably utilized at an isotonic saline concentration and may be adjusted with hypertonic saline. The solution may be used for the in vitro treatment of infected whole blood, blood cells or plasma to reduce contamination and is effective in treatment of fluids infected with HIV, hepatitis and other viral, bacterial and fungal agents.
    Type: Grant
    Filed: August 30, 1996
    Date of Patent: March 24, 1998
    Assignee: Medical Discoveries, Inc.
    Inventor: Robert E. Morrow
  • Patent number: 5674537
    Abstract: A microbiocidal solution for in vivo and in vitro treatment of microbial infections containing an electrolyzed saline solution having a content of regulated amounts of ozone and active chlorine species. The ozone content is 5 to 100 mg/L (milligram per liter) and the chlorine species content is 5 to 300 parts per million (ppm). The active chlorine species comprises free chlorine, hypochlorous acid and the hypochlorite ion as measured by a chlorine selective electrode. The solution is prepared by subjecting a 1% or less saline to electrolysis under conditions sufficient to produce the active ingredients. The solution is used at an isotonic saline concentration and my be adjusted with hypertonic saline. The solution is used in vitro treatments of infected whole blood, blood cells or plasma to reduce contamination. The solution may also be administered to warm blooded animals, including humans by intravenous injection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 7, 1997
    Assignee: Medical Discoveries, Inc.
    Inventor: Robert E. Morrow
  • Patent number: 5622848
    Abstract: A microbiocidal solution for in vivo and in vitro treatment of microbial infections includes an electrolyzed saline containing regulated amounts of ozone and active chlorine species wherein the ozone content is between about 5 and 100 mg/L and the active chlorine species content of between about 5 and 300 ppm. The active chlorine species comprises free chlorine, hypochlorous acid and the hypochlorite ion as measured by a chlorine selective electrode. The solution is prepared by subjecting a 1% or less saline to electrolysis under conditions sufficient to produce the desired active ingredients. The solution is preferably utilized at an isotonic saline concentration and may be adjusted with hypertonic saline. The solution may be used for the in vitro treatment of infected whole blood, blood cells or plasma to reduce contamination and is effective in treatment of fluids infected with HIV, hepatitis and other viral, bacterial and fungal agents.
    Type: Grant
    Filed: July 15, 1994
    Date of Patent: April 22, 1997
    Assignee: Medical Discoveries, Inc.
    Inventor: Robert E. Morrow
  • Patent number: 5334383
    Abstract: A method of treating antigen related infections is disclosed which comprises subjecting a dilute normal saline solution to electrical hydrolysis with adequate voltage to produce a solution containing bioactive microbicidal atoms, radicals or ions selected from the group consisting of chloride , ozone, hydroxide, hypochlorite, peroxide, chlorine dioxide, and oxygen with corresponding amounts of molecular hydrogen and sodium and hydrogen ions. The solution is balanced to normal saline with hypertonic saline. The injecting of effective amounts of the balanced solution intravenously into a warm blooded animal affected by an antigenic related infection results in a microbicidal action which mimics or enhances action of the free radicals produced in vivo as a result of respiratory bursts.
    Type: Grant
    Filed: May 23, 1990
    Date of Patent: August 2, 1994
    Assignee: Medical Discoveries, Inc.
    Inventor: Robert E. Morrow